BioCentra Revenue and Competitors

Austin, TX USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • BioCentra's estimated annual revenue is currently $1.6M per year.(i)
  • BioCentra's estimated revenue per employee is $155,000

Employee Data

  • BioCentra has 10 Employees.(i)
  • BioCentra grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M11-8%N/AN/A
#2
$14.9M96-6%N/AN/A
#3
$15.2M983%$1.8MN/A
#4
$1.6M100%N/AN/A
#5
$3.4M220%N/AN/A
#6
$2.8M1850%N/AN/A
#7
$7.4M48-2%N/AN/A
#8
$0.8M50%N/AN/A
#9
$1.6M100%N/AN/A
#10
$16.3M10562%N/AN/A
Add Company

What Is BioCentra?

Building bridges at the intersection of Biotechnology and Medicine. Our Vision: By playing an active role in advancing innovation and helping collaborating organizations in transferring or adopting cutting-edge technologies, BioCentra is committed to leading an ecosystem that offers hope to patients, accelerates development of effective therapies, simplifies access to affordable care, encourages technological competence of its clients from developing nations with western partners, opens avenues of regional growth and increased global economic opportunity, while adhering to the highest standards of excellence in technology innovation, product development and strategic consulting with high standards of professional integrity and business ethics that is considerate of human, moral, religious, economic and community values. Our Mission: BioCentra was incorporated with a mission of advancing biomedical science and biotechnology through technology innovation, new product development, customized research services, strategic consulting and project management by collaborating with industry and academia, both nationally and internationally.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1M10-33%N/A
#2
$0.9M1011%N/A
#3
$1M11N/AN/A
#4
$1M1110%N/A
#5
$1M1110%N/A